Literature DB >> 17927569

Violacein: properties and biological activities.

Nelson Durán1, Giselle Z Justo, Carmen V Ferreira, Patrícia S Melo, Livia Cordi, Dorival Martins.   

Abstract

The violet pigment violacein is an indole derivative, isolated mainly from bacteria of the genus Chromobacterium, which exhibits important antitumoral, antimicrobial and antiparasitary properties. Furthermore, the formulation of violacein in different polymeric carriers developed so far offers alternative approaches to overcoming physiological barriers and undesirable physicochemical properties in vivo, thus improving its efficacy.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17927569     DOI： 10.1042/BA20070115

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN： 0885-4513            Impact factor:   2.431


  47 in total

1.  Antifungal activity of violacein purified from a novel strain of Chromobacterium sp. NIIST (MTCC 5522).

Authors:  Anju Sasidharan; Nishanth Kumar Sasidharan; Dileepkumar Bhaskaran Nair Saraswathy Amma; Radhakrishnan Kokkuvayil Vasu; Anupama Vijaya Nataraja; Krishnakumar Bhaskaran
Journal:  J Microbiol       Date:  2015-10-02       Impact factor: 3.422

2.  Purple-pigmented violacein-producing Duganella spp. inhabit the rhizosphere of wild and cultivated olives in southern Spain.

Authors:  Sergio Aranda; Miguel Montes-Borrego; Blanca B Landa
Journal:  Microb Ecol       Date:  2011-03-22       Impact factor: 4.552

3.  Nonphotosynthetic pigments as potential biosignatures.

Authors:  Edward W Schwieterman; Charles S Cockell; Victoria S Meadows
Journal:  Astrobiology       Date:  2015-05-05       Impact factor: 4.335

4.  Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo.

Authors:  Laura Masuelli; Fabrizio Pantanella; Giuseppe La Regina; Monica Benvenuto; Massimo Fantini; Rosanna Mattera; Enrica Di Stefano; Maurizio Mattei; Romano Silvestri; Serena Schippa; Vittorio Manzari; Andrea Modesti; Roberto Bei
Journal:  Tumour Biol       Date:  2015-10-13

Review 5.  Exoplanet Biosignatures: A Review of Remotely Detectable Signs of Life.

Authors:  Edward W Schwieterman; Nancy Y Kiang; Mary N Parenteau; Chester E Harman; Shiladitya DasSarma; Theresa M Fisher; Giada N Arney; Hilairy E Hartnett; Christopher T Reinhard; Stephanie L Olson; Victoria S Meadows; Charles S Cockell; Sara I Walker; John Lee Grenfell; Siddharth Hegde; Sarah Rugheimer; Renyu Hu; Timothy W Lyons
Journal:  Astrobiology       Date:  2018-05-04       Impact factor: 4.335

6.  Violacein inhibits matrix metalloproteinase mediated CXCR4 expression: potential anti-tumor effect in cancer invasion and metastasis.

Authors:  Derek Platt; Suneetha Amara; Toral Mehta; Koen Vercuyssee; Elbert L Myles; Terrance Johnson; Venkataswarup Tiriveedhi
Journal:  Biochem Biophys Res Commun       Date:  2014-12-05       Impact factor: 3.575

Review 7.  Chromobacterium violaceum and its important metabolites--review.

Authors:  M Durán; A Faljoni-Alario; N Durán
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

8.  Antitumoral activity of L-ascorbic acid-poly- D,L-(lactide-co-glycolide) nanoparticles containing violacein.

Authors:  Dorival Martins; Lucas Frungillo; Maristela C Anazzetti; Patrícia S Melo; Nelson Durán
Journal:  Int J Nanomedicine       Date:  2010-02-02

9.  Biosynthesis of Violacein, Structure and Function of l-Tryptophan Oxidase VioA from Chromobacterium violaceum.

Authors:  Janis J Füller; René Röpke; Joern Krausze; Kim E Rennhack; Nils P Daniel; Wulf Blankenfeldt; Stefan Schulz; Dieter Jahn; Jürgen Moser
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

10.  Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo.

Authors:  Stefanie C P Lopes; Yara C Blanco; Giselle Z Justo; Paulo A Nogueira; Francisco L S Rodrigues; Uta Goelnitz; Gerhard Wunderlich; Gustavo Facchini; Marcelo Brocchi; Nelson Duran; Fabio T M Costa
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.